Diffuse cortical atrophy in a marmoset model of multiple sclerosis

Neuroscience Letters

Volumn 437, Issue 2, 2008, Pages 121-124

  Pomeroy, Ian M ^a   Jordan, Elaine K ^b   Frank, Joseph A ^b   Matthews, Paul M ^a   Esiri, Margaret M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Callithrix jacchus; Cortical atrophy; Cortical lesions; Experimental autoimmune encephalomyelitis; Marmoset; Multiple sclerosis

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; BRAIN CORTEX; BRAIN CORTEX LESION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; MARMOSET; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

AGE FACTORS; ANIMALS; ATROPHY; CALLITHRIX; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MULTIPLE SCLEROSIS;

EID: 42749087378     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.03.069     Document Type: Article

References (21)

1. Bo L., Vedeler C.A., Nyland H.I., Trapp B.D., and Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62 (2003) 723-732
2. Chard D.T., Brex P.A., Ciccarelli O., Griffin C.M., Parker G.J.M., Dalton C., Altmann D.R., Thompson A.J., and Miller D.H. The longitudinal relation between brain lesion load and atrophy in multiple sclerosis: a 14 year follow up study. J. Neurol. Neurosurg. Psychiatry 74 (2003) 1551-1554
3. Charil A., Dagher A., Lerch J.P., Zijdenbos A.P., Worsley K.J., and Evans A.C. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 34 (2007) 509-517
4. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., and Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23 (2004) 1168-1175
5. Dalton C.M., Chard D.T., Davies G.R., Miszkiel K.A., Altmann D.R., Fernando K., Plant G.T., Thompson A.J., and Miller D.H. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 127 (2004) 1101-1107
6. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., Guidi L., Ghezzi A., Montanari E., Cifelli A., Federico A., and Smith S.M. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60 (2003) 1157-1162
7. Evangelou N., Esiri M.M., Smith S., Palace J., and Matthews P.M. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann. Neurol. 47 (2000) 391-395
8. Falke E., Nissanov J., Mitchell T.W., Bennett D.A., Trojanowski J.Q., and Arnold S.E. Subicular dendritic arborization in Alzheimer's disease correlates with neurofibrillary tangle density. Am. J. Pathol. 163 (2003) 1615-1621
9. Inglese M., Ge Y., Filippi M., Falini A., Grossman R.I., and Gonen O. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 21 (2004) 1825-1829
10. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Bruck W., Rauschka H., Bergmann M., Schmidbauer M., Parisi J.E., and Lassmann H. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 (2005) 2705-2712
11. Merkler D., Boscke R., Schmelting B., Czeh B., Fuchs E., Bruck W., and Stadelmann C. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol. 16 (2006) 117-123
12. Merkler D., Schmelting B., Czeh B., Fuchs E., Stadelmann C., and Bruck W. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult. Scler. 12 (2006) 369-374
13. Paolillo A., Pozzilli C., Gasperini C., Giugni E., Mainero C., Giuliani S., Tomassini V., Millefiorini E., and Bastianello S. Brain atrophy in relapsing-remitting multiple sclerosis: relationship with 'black holes', disease duration and clinical disability. J. Neurol. Sci. 174 (2000) 85-91
14. Peterson J., Bo L., Mork S., Chang A., and Trapp B. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50 (2001) 389-400
15. Pomeroy I.M., Matthews P.M., Frank J.A., Jordan E.K., and Esiri M.M. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 128 (2005) 2713-2721
16. Sailer M., Fischl B., Salat D., Tempelmann C., Schonfeld M.A., Busa E., Bodammer N., Heinze H.J., and Dale A. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 126 (2003) 1734-1744
17. Scheff S.W., Price D.A., Schmitt F.A., and Mufson E. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27 (2006) 1372-1384
18. Thompson P.M., Hayashi K.M., Sowell E.R., Gogtay N., Giedd J.N., Rapoport J.L., de Zubicaray G.I., Janke A.L., Rose S.E., Semple J., Doddrell D.M., Wang Y., van Erp T.G., Cannon T.D., and Toga A.W. Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage 23 Suppl. 1 (2004) S2-S18
19. Vercellino M., Plano F., Votta B., Mutani R., Giordana M.T., and Cavalla P. Grey matter pathology in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 1101-1107
20. Waxman S. Axonal conduction and injury in multiple sclerosis: the role of sodium channels. Nat. Rev. Neurosci. 7 (2006) 932-941
21. Wegner C., Esiri M.M., Chance S.A., Palace J., and Matthews P.M. Neocortical neuronal synaptic and glial loss in multiple sclerosis. Neurology 67 (2006) 960-967